mTOR 通路畸变的临床试验
总计2017个结果
-
Aadi Bioscience, Inc.批准上市TSC1 | TSC2 | PEComa,恶性 | mTOR 通路畸变
-
Zhejiang Cancer Hospital完全的
-
Taipei Medical University Shuang Ho Hospital完全的
-
University Hospital, Rouen完全的Transduction Pathway | Proteinic Synthesis | Proteolytic System法国
-
Huashan HospitalShanghai Municipal Science and Technology Commission完全的Glioma, Motor Pathway中国
-
Qilu Pharmaceutical Co., Ltd.招聘中
-
Medical University of GdanskNational Science Centre, Poland主动,不招人
-
BioMed Valley Discoveries, Inc终止晚期实体瘤 | MAP2K1基因突变 | BRAF基因突变 | MEK突变 | BRAF 基因改变 | 丁酮变更 | MAP2K1 基因改变 | MAP2K2基因突变 | MAP2K2 基因改变美国
-
Suzhou Genhouse Bio Co., Ltd.Shanghai East Hospital; Shandong Tumor Hospital招聘中
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS)完全的
-
United States Army Research Institute of Environmental...United States Department of Defense完全的
-
Northumbria University完全的
-
Bakirkoy Dr. Sadi Konuk Research and Training Hospital完全的子宫内膜异位症 | Apoptotic Pathway Deregulation火鸡
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Unilever R&D完全的
-
New York City Health and Hospitals Corporation终止
-
Wrocław University of Science and TechnologyWroclaw Medical University主动,不招人
-
Dana-Farber Cancer InstituteNovartis Pharmaceuticals完全的
-
Brighton and Sussex University Hospitals NHS TrustKing's College London; European Society of Cataract and Refractive Surgeons完全的
-
Hitit University完全的
-
Cornea and Laser Eye Institute招聘中
-
Universitaire Ziekenhuizen KU LeuvenOslo University Hospital; University of Bordeaux; KU Leuven; University College Dublin; Catharina... 和其他合作者尚未招聘
-
Al-Azhar University完全的血管内皮生长因子过表达 | Membrane Alteration埃及
-
Grupo Español de Rehabilitación Multimodal主动,不招人
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLC邀请报名
-
University of Dublin, Trinity CollegeActial Farmaceutica S.r.l.未知
-
TransThera Sciences (Nanjing), Inc.完全的